NeuroMetrix, Inc. Announces Day for Fourth Quarter and Comprehensive Year 2020 Monetary Effects Conference Call

The MarketWatch News Department was not included in the generation of this written content.

WOBURN, Mass., Jan 22, 2021 (Globe NEWSWIRE by way of COMTEX) —
WOBURN, Mass., Jan. 22, 2021 (Globe NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) announced nowadays that it ideas to issue its 2020 fourth quarter and complete yr economic outcomes in advance of the opening of the market place on January 28, 2021. The Enterprise will host a convention call at 8:00 a.m., Jap Time on January 28, 2021 to discuss its economical final results as properly as organization developments affecting the Business.

The meeting call could be accessed in the United States by dialing 844-787-0799 and using the confirmation code 8694435. Internationally, the conference simply call may perhaps be accessed by dialing 661-378-9630 and using the very same confirmation code. The earnings push release and accompanying condensed fiscal statements will be accessible from the Firm’s web page at www.NeuroMetrix.com under the “Investor Relations” tab.

A replay of the convention get in touch with will be accessible beginning two several hours right after the call by dialing 855-859-2056, domestically and 404-537-3406, internationally. The confirmation code to accessibility the replay is 8694435. The replay will be readily available for a single 7 days right after the convention simply call.

About NeuroMetrix

NeuroMetrix is an innovation-driven corporation targeted on the enhancement and international commercialization of non-invasive health-related equipment for the diagnosis and procedure of problems involving the anxious process. The Corporation has 3 commercial items. DPNCheck(R) is a diagnostic system that provides quick, stage-of-care detection of peripheral neuropathies. Advance(TM) is a diagnostic product that offers automatic, in-business office nerve conduction studies for the evaluation of focal neuropathies. Quell(R) is a wearable neurostimulation unit indicated for symptomatic aid of long-term agony that is out there over-the-counter. For far more info, visit www.NeuroMetrix.com.

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Main Economical Officer
neurometrix.ir@neurometrix.com

Source: NeuroMetrix, Inc.

COMTEX_378618054/2471/2021-01-22T11:05:39

Is there a difficulty with this push release? Contact the source service provider Comtex at editorial@comtex.com. You can also get in touch with MarketWatch Purchaser Provider through our Client Center.

(C) Copyright 2021 GlobeNewswire, Inc. All legal rights reserved.

The MarketWatch Information Section was not included in the development of this content.

Rachel C. Carpenter

Next Post

Bank of the James Announces Fourth Quarter, Full Year 2020 Financial Results and Declaration of Dividend

Sat Jan 23 , 2021
LYNCHBURG, Va., Jan. 22, 2021 (GLOBE NEWSWIRE) — Bank of the James Financial Group, Inc. (the “Company”) (NASDAQ:BOTJ), the parent company of Bank of the James, a full-service commercial and retail bank serving Region 2000 (the greater Lynchburg MSA), and the Blacksburg, Charlottesville, Harrisonburg, Lexington, and Roanoke, Virginia markets, today […]